Notably, IGF2BP2 mRNA expression level was significantly associated with IGF2BP2 CNV, indicating that genomic amplification may be one of the underlying mechanisms for the abnormal expression of IGF2BP2 in human pancreatic cancer (Fig. 2g). This evidence concerns the gene IGF2BP2 and familial pancreatic carcinoma.